Imprivata and McKesson

"Imprivata's keen understanding of the needs of both caregivers and IT, coupled with its deep healthcare experience, made it the best fit for Phoebe Putney. With Imprivata OneSign, we are able to strike the balance between IT security and clinician productivity — while saving time, work and money."

— Mike Elder, Director of Technical Services
Phoebe Putney Memorial Hospital
Albany, GA
 

"As we added applications and users, the time savings were compounded. An individual clinician can recover up to 30 minutes of productive time each day using single sign-on. We estimate that we save the equivalent of a full-time employee's time each day using OneSign."

— Christopher Paidhrin, Security and Compliance Officer
PeaceHealth Southwest Medical Center
Vancouver, WA

Imprivata and McKesson have been partners since 2009 with more than 50 joint customers, including Phoebe Putney Memorial Hospital, PeaceHealth Southwest Medical Center, Spencer Hospital, OhioHealth's Dublin Methodist Hospital, Fairfield Medical Center and Henry County Medical Center.

By integrating McKesson Paragon and McKesson Horizon with the OneSign ProveID™ API, McKesson customers benefit from medication order and prescription signing with just a tap of a badge or swipe of a fingerprint. A trusted solution, Imprivata OneSign® is approved by the Ohio Board of Pharmacy for the strong authentication required for medication orders, administration and dispensing in that state.

The Imprivata Difference

Imprivata OneSign supports a broad range of authentication modalities and technology infrastructures. It enhances care delivery by optimizing clinical workflows, enabling fast, secure access to patient information and increasing your McKesson utilization.

As the leader in secure access and collaboration for healthcare, Imprivata has received recognition from leading industry publications and analysts, including:

  • American Hospital Association exclusive endorsement
  • Rated #1 in KLAS SSO Report “To Identity Management and Beyond” (December 2010)
  • Strong Positive Rating in Gartner's 2011 Marketscope